Top
What People Are Saying

“SimpleCTMS is easy to use and supports ‘real-world’ clinical operations. From set-up to close-out, the SimpleCTMS team is always there to guide and provide support. The system is superb and the customer service is top-notch.”

Senior Partner, InClin

“SimpleCTMS is the only full service product we found that includes training, unlimited sandbox use, and experienced clinical and technical know-how to immediately assist. Wow, and your customer support is amazing. Great job!”

Director of Clin Ops, Biotech company

“Nothing beats having the system designed from the ground up by someone who has actually run clinical trials. SimpleCTMS scores highly because it has obviously been designed by a team who has been involved at a high level managing clinical trials.”

CEO, EU-based CRO

More testimonials...

Site Search
Follow Us on Twitter
« Will my eClinical data be available when I need it? Part 4 of key questions to ask an eClinical SaaS Vendor. | Main | The Next-Generation CTMS: Leveraging the Best of Excel™, Sharepoint™, and the Internet »
Monday
May092011

Pleased to announce the licensing agreement with Pearl Therapeutics for SimpleCTMS

AuthorJon Cecchettini | DateMonday, May 9, 2011 at 5:52PM
We are very pleased to announce that Pearl Therapeutics, Inc., a US based biopharmaceutical company, has selected SimpleCTMS as their CTMS vendor to optimize the management of their global clinical studies.  
The initial Pearl deployment includes multiple Phase II global studies in which SimpleCTMS will be deployed for study startup planning and ongoing study tracking. SimpleCTMS will improve data transparency across service providers, and integrate with other key eClinical systems utilized by Pearl.
|

PrintView Printer Friendly Version

EmailEmail Article to Friend